Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated …

Nov 20, 2025 · News surrounding Illumina’s ongoing antitrust legal battles and recent strategic shifts, such as updates on the planned divestiture of GRAIL, have kept investors on edge. …

We are Illumina We are a global genomics and human health leader innovating the future of precision health. We develop DNA sequencing and array-based life sciences technologies to …

2 days ago · Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function.

Illumina offers a broad range of sequencing and microarray products for diverse genomic analysis applications.

1 day ago · Key Points Spyglass Capital increased its Illumina stake by 25% to 698,565 shares (about $66.65M), making ILMN roughly 3.8% of Spyglass’s portfolio and its 11th-largest …

Dec 18, 2023 · Illumina’s decision to unwind its acquisition of Grail ensures the market for cancer detection tests remains competitive and delivers a choice of high-quality tests for patients and …

Nov 19, 2025 · A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, …

View a complete list of Illumina sequencing and microarray products. Filter by system compatibility and other key features to narrow the list.